JP2002539829A5 - - Google Patents

Download PDF

Info

Publication number
JP2002539829A5
JP2002539829A5 JP2000608747A JP2000608747A JP2002539829A5 JP 2002539829 A5 JP2002539829 A5 JP 2002539829A5 JP 2000608747 A JP2000608747 A JP 2000608747A JP 2000608747 A JP2000608747 A JP 2000608747A JP 2002539829 A5 JP2002539829 A5 JP 2002539829A5
Authority
JP
Japan
Prior art keywords
amino acid
arg
replaced
substituted
ala
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000608747A
Other languages
English (en)
Japanese (ja)
Other versions
JP4590504B2 (ja
JP2002539829A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2000/006418 external-priority patent/WO2000058466A2/en
Publication of JP2002539829A publication Critical patent/JP2002539829A/ja
Publication of JP2002539829A5 publication Critical patent/JP2002539829A5/ja
Application granted granted Critical
Publication of JP4590504B2 publication Critical patent/JP4590504B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000608747A 1999-03-30 2000-03-20 プロテアーゼ耐性flint類似体 Expired - Fee Related JP4590504B2 (ja)

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
US12683999P 1999-03-30 1999-03-30
US14007399P 1999-06-21 1999-06-21
US14707199P 1999-08-04 1999-08-04
US16052499P 1999-10-20 1999-10-20
US16066999P 1999-10-21 1999-10-21
US17274499P 1999-12-20 1999-12-20
US17818400P 2000-01-26 2000-01-26
US60/172,744 2000-01-26
US60/147,071 2000-01-26
US60/140,073 2000-01-26
US60/160,669 2000-01-26
US60/126,839 2000-01-26
US60/178,184 2000-01-26
US60/160,524 2000-01-26
PCT/US2000/006418 WO2000058466A2 (en) 1999-03-30 2000-03-20 Protease resistant flint analogs

Publications (3)

Publication Number Publication Date
JP2002539829A JP2002539829A (ja) 2002-11-26
JP2002539829A5 true JP2002539829A5 (cg-RX-API-DMAC7.html) 2007-05-24
JP4590504B2 JP4590504B2 (ja) 2010-12-01

Family

ID=27568834

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000608747A Expired - Fee Related JP4590504B2 (ja) 1999-03-30 2000-03-20 プロテアーゼ耐性flint類似体

Country Status (8)

Country Link
EP (1) EP1165781B1 (cg-RX-API-DMAC7.html)
JP (1) JP4590504B2 (cg-RX-API-DMAC7.html)
AT (1) ATE371737T1 (cg-RX-API-DMAC7.html)
AU (1) AU3739500A (cg-RX-API-DMAC7.html)
CA (1) CA2368767C (cg-RX-API-DMAC7.html)
DE (1) DE60036199T2 (cg-RX-API-DMAC7.html)
ES (1) ES2291197T3 (cg-RX-API-DMAC7.html)
WO (1) WO2000058466A2 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69837996T2 (de) 1997-01-14 2008-02-28 Human Genome Sciences, Inc. Tumornekrosefaktor-rezeptoren 6 alpha& 6 beta
US7285267B2 (en) 1997-01-14 2007-10-23 Human Genome Sciences, Inc. Tumor necrosis factor receptors 6α & 6β
WO1999014330A1 (en) 1997-09-18 1999-03-25 Genentech, Inc. DcR3 POLYPEPTIDE, A TNFR HOMOLOG
CA2368760A1 (en) * 1999-03-30 2000-10-05 Eli Lilly And Company Flint polypeptide analogs
AU1189101A (en) * 1999-10-20 2001-04-30 Eli Lilly And Company Therapeutic applications of flint polypeptides
WO2002060947A2 (en) * 2001-02-01 2002-08-08 Eli Lilly And Company Glycoforms a fas ligand inhibitory protein analog
JP2005506282A (ja) * 2001-02-01 2005-03-03 イーライ・リリー・アンド・カンパニー Flintグリコフォーム
EP1447093A1 (en) 2003-02-14 2004-08-18 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Inhibition of the CD95 ligand/receptor system for the treatment of neurological disorders and injuries
CA3112788A1 (en) 2018-09-05 2020-03-12 Arizona Board Of Regents On Behalf Of Arizona State University Oncolytic virus platform to treat hematological cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69837996T2 (de) * 1997-01-14 2008-02-28 Human Genome Sciences, Inc. Tumornekrosefaktor-rezeptoren 6 alpha& 6 beta
WO1999014330A1 (en) * 1997-09-18 1999-03-25 Genentech, Inc. DcR3 POLYPEPTIDE, A TNFR HOMOLOG
HUP0102067A2 (hu) * 1998-03-30 2001-10-28 Eli Lilly And Co. A TNF receptorcsaládba tartozó érett FLINT (mFLINT) polipeptid vagy más néven az OPG3 terápiás alkalmazásai

Similar Documents

Publication Publication Date Title
JP2020023567A5 (cg-RX-API-DMAC7.html)
CN101622271B (zh) 抗微生物肽
CN104507489B (zh) 用于预防和治疗类风湿性关节炎的组合物
HU211348A9 (en) Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
CA2370289A1 (en) Neuronal exocytosis inhibiting peptides and cosmetic and pharmaceutical compositions containing said peptides
KR890003802A (ko) 재조합 dna 기술에 의해 제조된 소의 췌장 트립신 억제제, 그 제조 방법, 발현 벡터 및 재조합 숙주 및 그의 제약적 용도
JPH10509428A (ja) 活性依存性神経栄養因子の神経栄養ペプチド
CA2340328A1 (en) Stable hypoxia inducible factor-1 alpha and method of use
CA2489227A1 (en) Hla-a24-restricted cancer antigen peptides
CA2529179A1 (en) Recombinant adeno-associated virus vector for treatment of alzheimer disease
CA2482598A1 (en) Peptide inhibitors of protein kinase c
KR940703854A (ko) 사람 쿠니즈형 프로테아제 저해제 변이체(a human kunitz-type protease inhibitor variant)
YU71395A (sh) Acilovani analozi insulina
KR970705405A (ko) 사람 케모킨 폴리펩타이드(Human Chemokine Polypeptides)
WO1990009162A2 (en) Anaphylatoxin-receptor ligands
JP2024502463A5 (cg-RX-API-DMAC7.html)
US5387671A (en) Hexa- and heptapeptide anaphylatoxin-receptor ligands
JP2002522508A5 (cg-RX-API-DMAC7.html)
JP2008522954A5 (cg-RX-API-DMAC7.html)
CN110831957B (zh) Apoc-ii模拟肽
JP2002518011A5 (cg-RX-API-DMAC7.html)
CN101808655B (zh) 衍生自纤溶酶原激活物抑制剂-1的肽和其应用
RU2727013C2 (ru) Циклические аналоги галанина и пути их применения
JP2021531246A5 (cg-RX-API-DMAC7.html)
JP2017530128A (ja) 肝細胞増殖因子及びストローマ細胞由来因子1αを用いた末梢動脈疾患の予防または治療用組成物